Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001853529-26-000002

Chief Scientific Officer sold 5,901 shares at an average $43.73 ($258,042)

  • Chief Scientific Officer acquired 12,812 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Russell Alan J · Chief Scientific Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-12 Exercise or conversion : show line 1 in the form +5,781 30,336 D
2026-08-12 Exercise or conversion : show line 2 in the form +7,031 37,367 D
2026-08-12 Sale : show line 3 in the form −3,238 $43.68 $141,428 34,129 D
2026-08-12 Sale : show line 4 in the form −2,273 $43.68 $99,275 31,856 D
2026-08-12 Sale : show line 5 in the form −390 $44.46 $17,339 31,466 D
Open-market sales · 5,901 sh · avg $43.73 · $258,042

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2026-08-12 Exercise or conversion : show line 6 in the form Restricted Stock Units −5,781 11,563 D
2026-08-12 Exercise or conversion : show line 7 in the form Restricted Stock Units −7,031 21,094 D
2026-08-12 Grant or award : show line 8 in the form Restricted Stock Units +32,500 32,500 D
2026-08-12 Grant or award : show line 9 in the form Stock Option (Right to Buy) +65,000 65,000 D
Loading xslF345X06/primarydocument.xml…